Pronóstico del mercado de fraccionamiento de plasma de Oriente Medio y África hasta 2028: impacto de COVID-19 y análisis regional por producto (inmunoglobulina, albúmina, concentrados de factores de coagulación, inhibidores de proteasa y otros productos plasmáticos), aplicación (neurología, inmunología, hematología, cuidados intensivos, neumología) y otras aplicaciones) y usuario final (hospitales y clínicas, laboratorios de investigación clínica e institutos académicos)
Introducción al mercado
Los Emiratos Árabes Unidos (EAU), Arabia Saudita y Sudáfrica son los 3 principales países del MEA. Arabia Saudita fue el mercado más grande de fraccionamiento de plasma en esta región en 2021. Se prevé que el mercado de fraccionamiento de plasma en MEA crezca a una tasa compuesta anual del 5,2% durante el período de pronóstico; este crecimiento se atribuye a la creciente prevalencia de diversas enfermedades y al aumento de las iniciativas gubernamentales en la región.
Las incertidumbres económicas y los conflictos en curso están empeorando la situación en la región. Por ejemplo, países como Siria, Libia y Yemen están sufriendo conflictos violentos y no pueden implementar medidas sólidas de salud pública. Irán se encontraba en una profunda recesión económica debido a las sanciones estadounidenses. Además, la principal fuente de estabilización económica en los países de Medio Oriente es la producción y exportación de petróleo. Sin embargo, la pandemia de COVID-19 está provocando turbulencias en las economías de Oriente Medio. Una caída repentina de la demanda interna y externa de bienes y productos, especialmente petróleo crudo, y la paralización de la producción debido a la escasez de mano de obra son los principales impactos observados en la región. La propagación de la COVID-19 en la región supuso una pesada carga para los profesionales de la salud. Los cirujanos cardíacos estaban sobrecargados con cirugías cardíacas de emergencia, manejo de pacientes con COVID-19 e implementación de pautas de seguridad para prevenir la propagación del virus. La rápida propagación del virus afectó las cirugías electivas. Por lo tanto, el brote de COVID-19 afectó negativamente el crecimiento del mercado de fraccionamiento de plasma MEA.
El fraccionamiento de plasma Se espera que el mercado en MEA crezca de 2.455,61 millones de dólares en 2021 a 3.490,73 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 5,2% de 2021 a 2028. El plasma sanguíneo se encuentra entre los métodos emergentes para tratar diversas enfermedades crónicas. El plasma está formado por componentes esenciales, como proteínas, albúmina, globulinas, fibrinógeno, factores e inhibidores de la coagulación, entre otros. Se usa ampliamente en cáncer de sangre, COVID19, fibrilación auricular, leucemia y otros. El plasma se separa de la sangre donada mediante fraccionamiento de plasma. Las agencias reguladoras también están proporcionando las aprobaciones necesarias para el uso de plasma en procesos de tratamiento. Por lo tanto, se espera que la participación activa y la aprobación de los reguladores y del gobierno fomenten la aplicación de plasma sanguíneo. El plasma sanguíneo se puede almacenar hasta por un año congelándolo dentro de las 24 horas posteriores a la donación de sangre para proteger los valiosos factores de coagulación y se puede utilizar después del proceso de descongelación. En todos los países se establecen muchos bancos de sangre, tienen acceso a proveedores de servicios de atención médica y están financiados por varios gobiernos y otras organizaciones. Por lo tanto, según los factores mencionados anteriormente, el mercado relacionado con el fraccionamiento de plasma sanguíneo en el período de pronóstico.
Segmentos de mercado clave
< p>El mercado de fraccionamiento de plasma MEA está segmentado en producto, aplicación, usuario final y país. El mercado de fraccionamiento de plasma MEA, según el producto, se ha segmentado en inmunoglobulinas, albúmina, concentrados de factores de coagulación, inhibidores de proteasa y otros. Es probable que el segmento de inmunoglobulinas tenga la mayor participación del mercado en 2021. El mercado de fraccionamiento de plasma MEA, según la aplicación, se segmenta en neurología, inmunología, hematología, cuidados intensivos, neumología y otros. En 2021, es probable que el segmento de Neurología tenga la mayor cuota de mercado. El mercado de fraccionamiento de plasma MEA, basado en el usuario final, se segmenta en hospitales y clínicas, laboratorios de investigación clínica e institutos académicos. En 2021, es probable que el segmento de hospitales y clínicas tenga la mayor participación del mercado. Según el país, el mercado de fraccionamiento de plasma de MEA está segmentado en Arabia Saudita, Sudáfrica, los Emiratos Árabes Unidos y el resto de MEA. El resto de MEA tuvo la mayor participación de mercado en 2021.Principales fuentes y empresas cotizadas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de fraccionamiento de plasma en MEA son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y la base de datos estadística, entre otros. otros. Las principales empresas que figuran en el informe son Bharat Serums and Vaccines Limited (BSV); Laboratorio de Productos Bio Ltd.; Biotest AG; CSL limitada; Grifols, SA; Kedrion SpA; Octapharma AG; y SK Plasma.
Razones para comprar informe
- Comprender el panorama del mercado de fraccionamiento de plasma MEA e identificar los segmentos de mercado que son más probablemente garantice un fuerte retorno.
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de fraccionamiento de plasma MEA.
- Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado de fraccionamiento de plasma MEA identificando segmentos de mercado con las ventas probables más prometedoras.
- Ayuda a tomar decisiones comerciales informadas desde una perspectiva perspicaz y análisis integral del desempeño del mercado de varios segmentos del mercado de fraccionamiento de plasma MEA.
- Obtener un pronóstico de ingresos de mercado para varios segmentos de 2021 a 2028 en la región MEA.
MEA Mercado de fraccionamiento de plasma Segmentación
Mercado de fraccionamiento de plasma MEA - Por producto
- Inmunoglobulina
- Inmunoglobulina intravenosa (IVIG)
- Inmunoglobulina subcutánea (SCIG) )
- Albúmina
- Concentrados de factor de coagulación
- Inhibidores de proteasa
- Otros
Mercado de fraccionamiento de plasma MEA - Por Aplicación
- Neurología
- Inmunología
- Hematología
- Cuidados críticos
- Neumología
- Otros
Mercado de fraccionamiento de plasma MEA: al final Usuario
- Hospitales y Clínicas
- Laboratorios de Investigación Clínica
- Institutos académicos
Mercado de fraccionamiento de plasma MEA - por país
- Arabia Saudita
- Sudáfrica
- Emiratos Árabes Unidos
- Resto del mercado MEA
Mercado de fraccionamiento de plasma MEA: perfiles de empresa
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, SA
- Kedrion SpA
- Octapharma AG
- SK Plasma >ul>
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Plasma Fractionation Market – By Product
1.3.2 MEA Plasma Fractionation Market – By Application
1.3.3 MEA Plasma Fractionation Market – By End User
1.3.4 MEA Plasma Fractionation Market – By Country
2. MEA Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plasma Therapy Getting Popular
5.1.2 Significant Rise in Participation of the Players in Market Developments
5.2 Market Restraints
5.2.1 Various Non-Plasma Substitutes Available
5.3 Market Opportunities
5.3.1 Emerging Countries Showing Development Capability
5.4 Future Trends
5.4.1 Plasma Therapy in the Treatment of Novel Diseases
5.5 Impact Analysis
6. Plasma Fractionation Market – MEA Analysis
6.1 MEA Plasma Fractionation Market Revenue Forecast and Analysis
7. MEA Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 MEA Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8. MEA Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 MEA Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. MEA Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 MEA Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. MEA Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 MEA Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 Overview
10.1.1.1.2 UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.3 UAE: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3.1 UAE: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.1.1.1.4 UAE: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.1.4.1 UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.2 Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.3 Saudi Arabia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3.1 Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.1.1.2.4 Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.2.5 Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.3 South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.3 South Africa: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3.1 South Africa: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.1.1.3.4 South Africa: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.3.4.1 South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.4 Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.3 Rest of MEA: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3.1 Rest of MEA: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.1.1.4.4 Rest of MEA: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.4.5 Rest of MEA: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on MEA Plasma Fractionation Market
11.1 MEA: Impact Assessment of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Followed by Major Market Players (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Biotest AG.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Octapharma AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Kedrion S.p.A
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CSL Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Grifols, S.A.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio Products Laboratory Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bharat Serums and Vaccines Limited (BSV)
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 SK Plasma
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. UAE: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. UAE: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 3. UAE: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of MEA: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of MEA: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of MEA: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of MEA: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic developments done by Companies
Table 19. Glossary of Terms, MEA Plasma Fractionation Market
LIST OF FIGURES
Figure 1. MEA Plasma Fractionation Market Segmentation
Figure 2. MEA Plasma Fractionation Market Segmentation, By Country
Figure 3. MEA Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in MEA Plasma Fractionation Market
Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6. MEA PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to MEA Plasma Fractionation Market
Figure 8. MEA Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. MEA Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10. MEA Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. MEA Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. MEA Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. MEA Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. MEA Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. MEA Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16. MEA Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. MEA Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18. MEA Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. MEA Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. MEA Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. MEA Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. MEA Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. MEA Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. MEA Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25. MEA Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. MEA Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. MEA Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. MEA Plasma Fractionation Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 29. MEA Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)
Figure 30. UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Impact of COVID-19 Pandemic in MEA Country Markets
Figure 35. Growth Strategies Followed by Major Market Players (%)
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- SK Plasma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA plasma fractionation market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the MEA plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution